Silk Road Medical to Present at the Morgan Stanley 2020 Healthcare Conference

Rhea-AI Summary

Silk Road Medical (Nasdaq: SILK), dedicated to stroke risk reduction, announced participation in the Morgan Stanley 2020 Healthcare Conference on September 18 at 11:45 a.m. Eastern Time. The event will feature a live webcast accessible via the company's Investors section. Silk Road Medical’s flagship treatment, the TransCarotid Artery Revascularization (TCAR), effectively addresses carotid artery blockages, aiming for better patient outcomes.

SUNNYVALE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Morgan Stanley 2020 Healthcare Conference.

Silk Road Medical’s management is scheduled to present on Friday, September 18 at 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.   

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company’s flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com

FAQ

When is Silk Road Medical's presentation at the Morgan Stanley 2020 Healthcare Conference?

Silk Road Medical will present on September 18, 2020, at 11:45 a.m. Eastern Time.

How can I access the live webcast of Silk Road Medical's conference presentation?

The live webcast can be accessed on the Investors section of Silk Road Medical's website.

What is Silk Road Medical's primary focus in the healthcare sector?

Silk Road Medical focuses on reducing stroke risks, primarily through its TransCarotid Artery Revascularization (TCAR) procedure.

What is the stock symbol for Silk Road Medical?

Silk Road Medical's stock symbol is SILK.

Where is Silk Road Medical located?

Silk Road Medical is based in Sunnyvale, California.